Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and …
Context Accurate staging of high-risk localised, advanced, and metastatic prostate cancer is
becoming increasingly more important in guiding local and systemic treatment. Gallium-68 …
becoming increasingly more important in guiding local and systemic treatment. Gallium-68 …
Metaanalysis of 68Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology
68Ga-PSMA-11 PET is used to stage patients with prostate cancer. We performed an
updated metaanalysis that separates imaging at the time of diagnosis and at the time of …
updated metaanalysis that separates imaging at the time of diagnosis and at the time of …
PET/MRI in prostate cancer: a systematic review and meta-analysis
L Evangelista, F Zattoni, G Cassarino, P Artioli… - European journal of …, 2021 - Springer
Aim In recent years, the clinical availability of scanners for integrated positron emission
tomography (PET) and magnetic resonance imaging (MRI) has enabled the practical …
tomography (PET) and magnetic resonance imaging (MRI) has enabled the practical …
A systematic review on the role of imaging in early recurrent prostate cancer
PJL De Visschere, C Standaert, JJ Fütterer… - European urology …, 2019 - Elsevier
Context In patients treated for prostate cancer, a rising serum prostate-specific antigen (PSA)
level is a first sign of relapse, but imaging is needed to determine the localization of the …
level is a first sign of relapse, but imaging is needed to determine the localization of the …
Current status of theranostics in prostate cancer
The aim of this review is to report on the current status of prostate-specific membrane
antigen (PSMA)-directed theranostics in prostate cancer (PC) patients. The value of 68 Ga …
antigen (PSMA)-directed theranostics in prostate cancer (PC) patients. The value of 68 Ga …
Use of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer …
HB Luiting, PJ van Leeuwen, MB Busstra… - BJU …, 2020 - Wiley Online Library
Objectives To review the literature to determine the sensitivity and specificity of gallium‐68
prostate‐specific membrane antigen (68Ga‐PSMA) positron‐emission tomography (PET) for …
prostate‐specific membrane antigen (68Ga‐PSMA) positron‐emission tomography (PET) for …
68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment …
Purpose The primary aim of this retrospective, single-centre analysis was to assess the
performance of 68 Ga-PSMA-11 PET/CT in prostate cancer (PCa) patients in early PSA …
performance of 68 Ga-PSMA-11 PET/CT in prostate cancer (PCa) patients in early PSA …
Diagnostic performance and clinical impact of 68Ga-PSMA-11 PET/CT imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study …
Biochemical recurrence (BCR) is a clinical challenge in prostate cancer (PCa) patients, as
recurrence localization guides subsequent therapies. The use of PET with prostate-specific …
recurrence localization guides subsequent therapies. The use of PET with prostate-specific …
First clinicopathologic evidence of a non–PSMA-related uptake mechanism for 68Ga-PSMA-11 in salivary glands
NJ Rupp, CA Umbricht, DA Pizzuto… - Journal of Nuclear …, 2019 - Soc Nuclear Med
The intense accumulation of prostate-specific membrane antigen (PSMA) radioligands in
salivary glands is still not well understood. It is of concern for therapeutic applications of …
salivary glands is still not well understood. It is of concern for therapeutic applications of …
A clinician's guide to next generation imaging in patients with advanced prostate cancer (RADAR III)
Purpose: The advanced prostate cancer therapeutic landscape has changed dramatically in
the last several years, resulting in improved overall survival of patients with castration naïve …
the last several years, resulting in improved overall survival of patients with castration naïve …